Comprehensive digital platform brings both clinical and
educational material regarding home dialysis together, creating a
powerful resource for UK healthcare professionals and
patients
LONDON, Sept. 17, 2018 /PRNewswire/ -- NxStage Medical,
Inc. (Nasdaq: NXTM), a leading medical technology company focused
on advancing renal care, today announced the launch of its new UK
website. The comprehensive website brings both clinical and
educational material regarding home dialysis together in one
location creating an invaluable resource for UK healthcare
professionals and patients.
The new website features a streamlined and simplified design,
improved functionality and rich content areas focused on kidney
disease, clinical data and home dialysis. For healthcare
professionals, the website provides clinical data, information on
the use of NxStage products, and guides for implementing best
practices in home haemodialysis. For patients, the website offers
educational information regarding kidney disease, treatment
modalities, advice for speaking with doctors, and insightful
stories from patients that have benefitted from home haemodialysis
and more frequent therapy.
"We've refined our website to make it easier to access relevant
clinical and educational material regarding home dialysis," stated
Matt Walker, NxStage Medical UK,
Ltd. "With a growing number of people needing dialysis in the UK,
this new resource demonstrates our continuing commitment to
increasing awareness and education about the life-changing benefits
possible with home haemodialysis."
The new website can be found at: https://www.nxstage.co.uk/
For more information contact:
Katie Elliott / nxstage@standagency.com / 0203
6965800
About NxStage Medical
NxStage Medical, Inc. (Nasdaq:
NXTM) is a leading medical technology company, headquartered in
the United States, that develops,
manufactures and markets innovative products for the treatment of
end-stage renal disease (ESRD) and acute kidney failure. For more
information on NxStage and its products and services, please visit
https://www.nxstage.co.uk/.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. Actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors including those that are
discussed in NxStage's filings with the Securities and Exchange
Commission, including its Quarterly Report on Form 10-Q for the
quarter ended June 30, 2018. NxStage
is under no obligation to (and expressly disclaims any such
obligation to) update or alter its forward-looking statements,
whether as a result of new information, future events or
otherwise.
Logo -
https://mma.prnewswire.com/media/321808/nxstage_medical__inc__logo.jpg